The design and discovery of DUB-targeting compounds is enabling the development of powerful new medicines

Learn more about why we focus on DUBs and the UPS

Our end-to-end platform is driving DUB targeted drug discovery and development

Discover our assays, expertise, and capabilities

We are harnessing DUBs and their modulators to develop an internal asset pipeline across core therapeutic areas

Discover our growing portfolio of novel DUB-targeting compounds

Together, we will realise the exciting potential of DUB-targeting compounds in drug development

Learn more about how our expertise supports partnerships

Our specialist services will power your DUB-focused research and drug discovery

Find out how we can support your DUB programmes

Ubiquigent™ has an unrivalled track record and unique range of specialist services focused on the exploitation of the DUB enzymes and ubiquitin-proteasome system (UPS).